Introduction to Alunbrig (Brigatinib) 90mg
Alunbrig (Brigatinib) 90mg is a prescription medicine used in the treatment of certain types of lung cancer, particularly non-small cell lung cancer (NSCLC) that is positive for anaplastic lymphoma kinase (ALK). This targeted therapy is designed to block specific cancer-causing signals that promote tumor growth.
Brigacent (Brigatinib) 90mg is classified under Prescription Medicines, Oncology Medicines, Targeted Cancer Therapies, and Oral Anticancer Drugs. It contains Brigatinib, which works by inhibiting abnormal ALK proteins responsible for uncontrolled cancer cell growth.
In some markets, Brigacent 90mg is available as a generic brand containing the same active ingredient Brigatinib, providing a similar therapeutic effect when prescribed by a qualified healthcare professional.
What Is Alunbrig (Brigatinib)?
Alunbrig is the original brand name for Brigatinib, an oral medication widely used in the treatment of certain advanced lung cancers.
Brigatinib belongs to a class of medicines known as Tyrosine Kinase Inhibitors (TKIs). These medicines target specific proteins involved in cancer cell growth and spread.
Generic versions such as Brigacent 90mg contain the same active compound and may be used depending on physician recommendation and regional availability.
Drug Class and Mechanism of Action
Brigatinib is classified as a targeted anticancer medicine and tyrosine kinase inhibitor with strong antineoplastic activity.
How Brigatinib Works
It works in several important ways:
- Blocking abnormal ALK protein activity responsible for tumor growth
- Preventing cancer cells from multiplying and spreading
- Interrupting cancer cell signaling pathways
- Slowing the progression of lung tumors
Through these mechanisms, Brigatinib helps control the growth and spread of ALK-positive lung cancer.
How Alunbrig Works in the Body
Certain lung cancers develop due to genetic changes that activate the ALK protein. This abnormal protein sends signals that promote uncontrolled cancer cell growth.
Key Actions of Brigatinib
- Inhibiting abnormal ALK enzyme activity
- Blocking cancer cell proliferation signals
- Reducing tumor growth and spread
- Helping control advanced lung cancer progression
Generic versions such as Brigacent deliver the same active compound, enabling similar targeted cancer treatment when prescribed appropriately.
Medical Uses of Alunbrig (Brigatinib) 90mg
Alunbrig 90mg is primarily prescribed for specific forms of lung cancer.
Alunbrig for ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
Brigatinib is commonly used in patients diagnosed with ALK-positive metastatic non-small cell lung cancer.
Potential Benefits
- Targeted inhibition of cancer-causing ALK proteins
- Slowing tumor progression
- Improved disease control in advanced lung cancer
- Support for longer progression-free survival
Generic alternatives like Brigacent 90mg may also be used under medical supervision when Brigatinib therapy is recommended.
Who Can Take Brigacent 90mg?
Because Brigatinib is a potent anticancer medicine, treatment should always be supervised by an experienced oncology specialist.
Eligibility Criteria
Patients may be prescribed Alunbrig if they:
- Are diagnosed with ALK-positive non-small cell lung cancer
- Have undergone genetic testing confirming ALK mutation
- Require targeted therapy for advanced or metastatic cancer
- Can undergo regular monitoring during treatment
Certain generic options such as Brigacent may also be considered depending on availability and physician recommendation.
Who Should Avoid Alunbrig (Brigatinib) 90mg
Alunbrig should NOT be used by:
- Patients with hypersensitivity to Brigatinib
- Individuals with severe lung inflammation without medical evaluation
- Patients with uncontrolled high blood pressure without supervision
Pregnant or breastfeeding women should consult their doctor before using Brigatinib due to potential risks to the fetus.
Alunbrig (Brigatinib) 90mg Dosage and Administration
Standard Dosage Guidelines
Typical dosage recommendations include:
- Brigacent 90mg once daily during the initial treatment period
- After tolerance assessment, the dose may be increased according to medical advice
- Tablets should be swallowed whole with water
- Can be taken with or without food
Dosage Adjustments
Doctors may adjust the dose depending on:
- Liver function
- Treatment tolerance
- Side effects experienced by the patient
- Individual therapeutic response
Side Effects of Alunbrig 90mg
Like many cancer medicines, Brigatinib may cause side effects.
Common Side Effects
- Nausea
- Fatigue
- Diarrhea
- Headache
- Muscle pain
Serious Side Effects
- Lung inflammation (interstitial lung disease)
- High blood pressure
- Slow heart rate
- Vision disturbances
- Elevated blood sugar levels
Patients should inform their healthcare provider immediately if severe symptoms appear.
Storage:
Store below 25°C in a cool, dry place away from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Frequently Asked Questions (FAQs)
1. What is Alunbrig (Brigatinib) 90mg used for?
Alunbrig is used to treat ALK-positive non-small cell lung cancer, especially in patients with advanced or metastatic disease.
2. Is Brigatinib a chemotherapy drug?
No. Brigatinib is a targeted therapy known as a tyrosine kinase inhibitor that specifically blocks cancer-causing proteins.
3. Can Brigacent 90mg cure lung cancer?
While it may not cure advanced cancer, Brigatinib can help control tumor growth and improve survival outcomes in many patients.
4. How long is Brigatinib treatment continued?
Treatment is usually continued as long as the medicine remains effective and the patient tolerates it well.
5. Can Brigacent 90mg be taken with food?
Yes. Brigatinib tablets can generally be taken with or without food unless advised otherwise by a doctor.
6. Is Brigacent 90mg the same as Alunbrig?
Brigacent 90mg contains Brigatinib, the same active ingredient found in Alunbrig. Generic versions is available. for more info. contact on WhatsApp: https://wa.me/8801742433764
7. Do I need a prescription to buy Brigacent (Brigatinib) 90mg?
Yes. Brigacent 90mg is a prescription-only medicine and must be used under the supervision of a qualified oncology specialist.
Medical Disclaimer
Disclaimer:
The information provided on this page is for educational and informational purposes only and should not be considered medical advice. Alunbrig (Brigatinib) is a prescription-only medication and must be used strictly under the supervision of a qualified healthcare professional. Always consult your physician before starting, stopping, or changing any medication.
